Jeffrey Erickson
Company: Triumvira Immunologics Inc
Job title: Vice President, Business Development
Seminars:
Next-Generation Cell Therapies Targeting Claudin: Overcoming Challenges & Improving Outcomes 12:00 pm
Showcasing the latest advancements in next-generation cell therapies targeting claudin, emphasizing novel approaches beyond CAR-T Understanding improvements in toxicity profiles and the durability of therapeutic responses in solid tumors Highlighting early clinical data and preclinical insights to illustrate the effectiveness and potential of these innovative therapiesRead more
day: Conference Day 2